查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840838

次世代定序儀樣品製備市場：按產品類型、工作流程、NGS技術、樣品類型、應用和最終用戶分類－2025-2032年全球預測

Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，次世代定序儀樣品製備市場規模將達到 145.2 億美元，複合年成長率為 12.47%。

關鍵市場統計數據
基準年 2024 56.7億美元
預計年份：2025年 63.4億美元
預測年份 2032 145.2億美元
複合年成長率 (%) 12.47%

了解如何最佳化樣本製備流程，這對於保護資料完整性、加速研究和改善臨床定序結果至關重要。

次世代定序儀(NGS) 已從一項革命性的實驗室技術發展成為現代生物學、診斷學和應用研究的基石。隨著定序通量和分析複雜性的不斷提高，定序前的各項流程——包括樣本採集、核酸提取、文庫建構、標靶富集和品管——已成為數據保真度和可解釋性的關鍵決定因素。穩健的樣本製備能夠確保所需的生物訊號得以保留並在下游儀器上穩定顯示，從而降低分析變異性，並加速將原始序列讀段轉化為可操作的洞見。

本報告透過分析技術進步、監管審查和營運需求三者如何共同影響學術、臨床和商業實驗室的實踐，強調了樣本製備的策略重要性。報告指出，試劑、自動化和方案標準化的改進對週轉時間、可重複性和單次結果成本有直接影響。因此，實驗室負責人和採購團隊必須將樣本製備視為定序價值鏈中不可或缺的一部分，而非僅僅是一項外圍的耗材成本。

最後，引言部分透過向相關人員提出關鍵問題，為深入分析奠定了基礎：不同的工作流程和耗材如何影響分析結果？哪些創新能夠大幅減少分析前誤差？以及各組織應如何優先考慮投資，以滿足科學目標和監管要求？在此框架下，後續章節概述了不斷變化的市場格局、監管阻力、市場細分資訊、區域動態、競爭格局以及為策略決策提供參考的實用建議。

評估技術創新、自動化和標準化如何重塑樣品製備並影響實驗室運作模式。

受技術創新、不斷變化的法規環境以及終端用戶對可重複、高品質資料日益成長的需求驅動，次世代定序儀的樣本製備領域正經歷著快速且多維度的變革。試劑化學和酵素學的進步使得文庫製備更加高效，所需樣本量更少，從而拓展了可分析的樣本類型。同時，自動化和微流體控技術的改進降低了人為操作的誤差，提高了定序通量。隨著定序定序擴大到群體層級研究和常規臨床診斷，這一點尤其重要。

伴隨這項技術變革而來的是對標準化和互通性的日益重視。實驗室間可重複性如今已成為臨床驗證和合作研究的核心指標，促使供應商和實驗室投資於檢驗的套件、封閉式工作流程和整合式品質控制解決方案。濕實驗室改進與資訊學賦能的品質查核點的整合，增強了從樣本收集到資料交付的可追溯性。此外，標靶序列捕獲純化和低起始量文庫構建等新型方法正在催生新的應用，例如循環腫瘤DNA譜分析和單細胞分析，這些應用需要專門的樣本製備策略。

因此，各機構正在重新思考其採購和營運模式。目前，市場明顯轉向整合儀器、試劑和服務的捆綁式解決方案，以最大限度地減少相容性問題並加快測試結果的獲取速度。供應商必須證明其產品與工作流程的兼容性以及符合監管要求，而實驗室則必須在標準化、檢驗的套件和平台的效率與客製化通訊協定的靈活性之間取得平衡。最終，這些變革性的變化正在重新定義整個樣本製備生態系統中對績效、可靠性和生命週期支援的期望。

檢驗關稅變化和貿易政策轉變對試劑採購、籌資策略和生產連續性造成的營運和供應鏈影響。

關稅變化和貿易政策調整會立即對次世代定序儀製備所需的試劑、設備和耗材的供應鏈造成壓力。在美國，已宣布或將於2025年實施的關稅，將為那些從海外供應商採購專用酶、塑膠和儀器零件的公司帶來新的成本考量和物流複雜性。這些變化迫使採購團隊重新評估供應商合約、前置作業時間緩衝和緊急庫存，以降低中斷風險並維持服務連續性。

為因應關稅帶來的不確定性，許多相關人員正在探索區域採購安排，以實現供應商網路多元化並降低跨境關稅風險。一些實驗室正在加快替代試劑形式和非供應商耗材的認證，以保持營運靈活性。同時，製造商正在調整定價策略，實現部分生產環節的在地化，並擴大經銷商夥伴關係，以抵銷貿易相關成本的直接影響。此類調整往往會帶來過渡期的摩擦，例如認證週期和潛在的批次間性能差異，這些都必須透過嚴格的品質控制通訊協定來管理。

從營運角度來看，科學研究機構在提昇科研績效的同時，也優先考慮供應鏈的韌性。這就要求制定風險評估方案，將關稅波動、前置作業時間變化以及對單一供應商的依賴等因素納入考量。同時，採購和實驗室負責人正加強合作，力求在短期保障措施和長期策略採購之間取得平衡，確保樣品製備流程在政策和貿易波動持續的情況下依然穩健運作。這種集體因應措施凸顯了靈活的籌資策略和供應商合作模式對於維護實驗完整性和服務交付的重要性。

提供細緻入微的細分訊息，將產品類型、工作流程、技術、樣品類別、應用和最終用戶優先順序連結起來，從而指南採購和開發。

要全面了解樣品製備領域，需要從多個細分維度進行深入分析，這些維度會影響採購行為、工作流程設計和技術相容性。基於產品考量，實驗室將儀器、試劑和耗材以及服務視為既獨立又相互依存的類別，這些類別共同決定了整體工作流程的性能和供應商的價值提案。儀器為通量和自動化設定了技術基準，試劑和耗材控制化學性能和批次一致性，而包括安裝和方法驗證在內的服務則確保了快速部署和運作可靠性。

從工作流程的角度來看，相關人員關注的是文庫製備和擴增、文庫定量和品管、核酸萃取以及標靶序列捕獲這幾個順序步驟，最佳化這些步驟能夠顯著提升資料品質。文庫製備和擴增技術對於維持樣本代表性和減少偏差至關重要，而穩健的定量和品質控制則能避免代價高昂的定序失敗。核酸萃取仍然是基礎步驟，萃取效率和抑制劑去除對於後續分析的成功至關重要。同時，標靶富集方法決定了後續分析（針對標靶panel和變異檢測）的特異性和靈敏度。

NGS技術的細分進一步細化了決策標準。諸如ChIP定序、EXOME定序、甲基化定序、RNA定序、標靶定序和全基因組定序等方法，各自對輸入品質、片段大小和富集策略提出了不同的要求。 DNA和RNA樣本類型的細分凸顯了不同的處理需求和穩定化通訊協定，其中RNA工作流程通常需要更嚴格的儲存和品質控制。從農業基因組學和動物科學到臨床診斷、臨床研究、藥物開發、消費者基因組學和法醫學，應用主導的優先事項正在影響驗證要求、通量容差和監管。最後，包括學術和研究機構、醫院和診所以及製藥和生物技術公司在內的最終用戶，有著獨特的採購理由和服務期望，這迫使供應商提供差異化的商業模式和技術支持，以滿足這些多樣化的需求。

了解區域法律規範、基礎設施投資和本地採購趨勢如何影響全球區域的採購重點和工作流程採用。

區域動態在塑造籌資策略、監管協調以及樣本製備技術的演進中發揮關鍵作用。在美洲，對臨床定序基礎設施和轉化研究中心的投資正在推動對自動化工作流程和檢驗套件的需求，以支援高通量和臨床級操作。隨著該地區的實驗室專注於臨床應用和大規模研究舉措，它們通常會優先考慮與現有設備的快速整合以及強大的售後支援。

在歐洲、中東和非洲，監管環境和醫療基礎設施的多樣性使得合規途徑和區域驗證至關重要。這些地區的實驗室正日益尋求既能促進跨境合作又能滿足嚴格的區域合規框架的解決方案。人們越來越關注能夠適應資源豐富的城市中心和需要可靠、簡化營運通訊協定的分散式設施的靈活工作流程。

在亞太地區，定序能力的快速擴張以及對基因組學主導的醫療保健和農業領域的投資，正在推動對具成本效益、高通量樣本製備解決方案的需求。在一些國家，本地製造和供應鏈措施正開始影響採購選擇，促使供應商考慮區域生產和分銷策略。然而，在不同地區，監管預期、報銷環境和研究重點相互作用，共同決定樣本製備設備、試劑和服務的投資重點。

闡述整合解決方案、夥伴關係策略和檢驗的績效數據如何幫助樣品製備生態系統中的供應商打造競爭優勢

樣品製備領域的競爭格局呈現出多元化的特點，既有成熟的儀器製造商，也有專業的試劑供應商，還有提供端到端工作流程解決方案和技術支援的服務供應商。許多領先企業專注於提供整合解決方案，將儀器與檢驗的試劑組和軟體支援的品管捆綁在一起，從而降低終端用戶的整合風險，並加速其在臨床和高通量研究環境中的應用。另一些企業則專注於小眾化學領域或新型萃取技術，以解決特定的難題，例如低起始量樣本或高度分解的核酸。

夥伴關係和通路策略正日益成為企業差異化的核心。那些能夠建立強大的經銷商網路、本地技術支援以及與終端用戶合作開發的供應商，能夠更快地應對需求波動和監管變化。此外，對測試方法驗證和已發布效能數據的投入，正成為實驗室管理人員和採購團隊越來越重要的決策依據。那些能夠在多項獨立研究中證明結果可重複性的公司，能夠增強潛在買家的信心，並降低他們更換試劑或平台時所面臨的風險。

創新流程也受到跨領域合作的影響。試劑公司、儀器原始設備製造商 (OEM) 和委外研發機構)之間的合作，能夠打造將一流組件與託管服務相結合的模組化解決方案。這種合作模式加速了產品改進，並常常為臨床和研究應用累積更廣泛的依證。最終，能夠顯著提升工作流程效率、可重複性和生命週期支持，同時又能根據需要靈活客製化的機構，將獲得競爭優勢。

為供應商和實驗室提供切實可行的、基於實證的舉措，以增強樣品製備工作流程中的檢驗、韌性和以客戶為中心的服務交付。

產業領導者可以採取一系列切實可行的措施，從技術、商業性和營運層面鞏固自身地位。首先，投資於工作流程驗證和互通性測試，確保儀器、套件和耗材在各種實驗室環境中都能穩定運行，從而降低客戶實施風險並縮短資格確認週期。其次，透過發布獨立的檢驗研究和提供清晰的品質控制指標，優先考慮績效數據的透明度，使採購團隊能夠進行基於數據的比較，並增強客戶對新解決方案的信心。

第三，透過供應商多元化、認證替代試劑形式以及發展區域分銷能力，增強供應鏈韌性並降低貿易中斷風險。第四，拓展服務範圍，整合技術培訓、方法轉移和售後支持，以最大限度地延長執行時間並減少用戶錯誤。第五，積極與相關人員和臨床合作夥伴溝通，預測合規要求，並使產品開發與臨床證據需求保持一致。透過這些舉措，各機構可以將自身定位為轉化研究和診斷應用領域值得信賴的合作夥伴。

最後，採用以客戶為中心的商業模式，在標準化、檢驗的快速部署套件與可設定的解決方案之間取得平衡，以滿足特定應用的需求。這種混合模式既能支持擴充性，又能維持高階研究計畫所需的靈活性。實施這些建議將提高營運的穩健性，加強客戶關係，並加速技術創新向可靠的實驗室實踐的轉換。

我們制定了一套嚴謹透明的研究途徑，將一手訪談、技術文獻和供應商文件結合，以確保研究結果具有可操作性和可複製性。

本研究結合了來自一手訪談、技術文獻和產品文件的定性和定量數據，以全面了解樣品製備流程和供應商策略。一手訪談包括與實驗室主任、採購負責人、試劑和儀器製造商的研發總監以及來自學術界、臨床和商業領域的技術服務經理進行的結構化討論。這些對話探討了工作流程中的痛點、驗證流程、供應商選擇標準和供應鏈考量，從而提供了關於行業動態的第一手資訊。

二級資訊來源包括同行評審出版物、監管指導文件以及說明方法、性能特徵和驗證方法的製造商技術說明。分析重點在於方法的可比較性、重現性指標以及試劑和儀器選擇對操作的影響。此外，調查團隊還透過供應商文件和公開的技術資訊評估了產品的整合和支持，並將相關聲明與實驗室經驗進行了交叉驗證。

我們的分析框架結合了主題綜合分析和跨細分維度的比較評估，旨在揭示通用的採用促進因素、技術權衡以及供應商差異化。在整個過程中，我們專注於提供能夠為策略決策提供依據的洞察，而不依賴專有的商業性估算，並且我們始終確保調查方法的透明性和可複製性。

策略要務概述：優先採用檢驗、可互通且具彈性的樣本製備方法，以維持定序可靠性和轉化應用價值。

總之，對於任何尋求可靠、高品質定序數據的機構而言，最佳化樣品製備都是至關重要的策略重點。試劑、自動化和品質控制方面的技術改進直接關係到下游分析的可重複性和靈敏度，而供應鏈和監管動態則影響採購選擇和營運韌性。因此，相關人員必須將樣品製備視為策略性投資，因為它會影響實驗成功率、實驗室通量和科學發現的可靠性。

整合解決方案、區域採購協調和循證檢驗等趨勢的整合，標誌著一個日益成熟的生態系統正在形成，該系統重視透明度、互通性和卓越服務。積極解決相容性、驗證和供應連續性的組織將更有利於掌握科研機會並減少營運中斷。最終，對樣本製備流程和供應商夥伴關係的明智投資將帶來更可靠的定序結果、加速轉化應用，並增強臨床和研究使用者的信心。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 微流體控平台的出現使得以最少的起始原料製備單細胞文庫成為可能。
  • 開發針對cfDNA和液態生物檢體樣本最佳化的低起始量和超低起始量文庫建構試劑套件
  • 將自動化和機器人技術整合到高通量NGS樣品製備工作流程中以實現可擴展性
  • 採用酵素DNA片段化技術取代機械剪切法來提高文庫完整性
  • 一種創新的條碼和獨特分子標識符方法，用於減少多重檢測中的擴增偏差
  • 標靶富集探針技術的進步使得從複雜樣本中高度特異性捕獲罕見基因組變異成為可能。
  • 實施即時品管和標準化系統，以最大限度地減少文庫製備失敗
  • 端到端樣本定序平台的日益普及將有助於加速臨床NGS診斷流程。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章次世代定序儀樣品製備市場（依產品分類）

  • 裝置
  • 試劑和耗材
  • 服務

第9章 依工作流程分類的次世代定序儀樣品製備市場

  • 文庫製備與擴增
  • 文庫定量/品質控制
  • 核酸萃取
  • 靶向序列捕獲

第10章次世代定序儀樣品製備市場 NGS技術

  • ChIP定序（染色質免疫沉澱定序）
  • EXOME定序
  • 甲基化定序
  • RNA定序（RNA-Seq）
  • 標靶定序
  • 全基因測序（WGS）

第11章 按樣品類型分類的次世代定序儀樣品製備市場

  • DNA
  • RNA

第12章次世代定序儀樣品製備市場（依應用領域分類）

  • 農業基因組學
  • 動物科學與獸醫研究
  • 臨床診斷
  • 臨床研究和藥物開發
  • 消費者基因體學
  • 法醫學

第13章次世代定序儀樣品製備市場（依最終用戶分類）

  • 學術研究機構
  • 醫院和診所
  • 製藥和生物技術公司

第14章次世代定序儀樣品製備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章次世代定序儀樣品製備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國次世代定序儀樣本製備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Agilent Technologies, Inc.
    • Azenta Life Sciences
    • BGI Genomics Co., Ltd.
    • Biodiscovery, LLC
    • Bio-Rad Laboratories, Inc.
    • Charles River Laboratories International, Inc
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • GenScript Biotech Corporation
    • Hamilton Bonaduz AG
    • Illumina, Inc.
    • LGC Biosearch Technologies
    • Merck KGaA
    • Meridian Bioscience, Inc
    • New England Biolabs, Inc
    • NimaGen BV
    • Omega Bio-tek, Inc.
    • Oxford Nanopore Technologies PLC
    • Pacific Biosciences of California, Inc.
    • Parse Biosciences
    • PerkinElmer, Inc.
    • Promega Corporation
    • QIAGEN NV
    • Standard BioTools Inc.
    • Takara Bio Inc.
    • Thermo Fisher Scientific, Inc.
    • Twist Bioscience Corporation
    • Zymo Research Corporation
Product Code: MRR-2214614769A0

The Next-Generation Sequencing Sample Preparation Market is projected to grow by USD 14.52 billion at a CAGR of 12.47% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.67 billion
Estimated Year [2025] USD 6.34 billion
Forecast Year [2032] USD 14.52 billion
CAGR (%) 12.47%

Introducing the strategic imperative for optimizing sample preparation workflows to safeguard data integrity, accelerate research, and enhance clinical sequencing outcomes

Next-generation sequencing (NGS) has evolved from a transformative laboratory technique into a foundational pillar for modern biology, diagnostics, and applied research. As sequencing throughput and analytical complexity have increased, the processes that precede sequencing-sample collection, nucleic acid extraction, library construction, target enrichment, and quality control-have emerged as critical determinants of data fidelity and interpretability. Robust sample preparation ensures that the biological signal of interest is preserved and presented consistently to downstream instruments, thereby reducing analytical variability and accelerating the translation of raw sequence reads into actionable insights.

This report introduces the strategic importance of sample preparation by examining the confluence of technological advancement, regulatory scrutiny, and operational demands that now shape practice in academic, clinical, and commercial laboratories. It emphasizes that improvements in reagents, automation, and protocol standardization have immediate impacts on turnaround time, reproducibility, and cost-per-result. Consequently, laboratory leaders and procurement teams must evaluate sample preparation not as a peripheral supply cost but as an integral component of the sequencing value chain.

Finally, the introduction sets the stage for deeper analysis by framing key questions for stakeholders: how do different workflows and consumables influence analytical outcomes; which innovations meaningfully reduce pre-analytical errors; and how should organizations prioritize investments to align with scientific objectives and regulatory expectations. With that framing in place, subsequent sections explore the landscape shifts, regulatory headwinds, segmentation intelligence, regional dynamics, competitive positioning, and practical recommendations that collectively inform strategic decisions.

Assessing how technological innovation, automation, and standardization are reshaping sample preparation practices and influencing laboratory operational models

The landscape of sample preparation for next-generation sequencing is undergoing rapid, multidimensional change driven by technological innovation, evolving regulatory environments, and the increasing expectations of end users for reproducible, high-quality data. Advances in reagent chemistry and enzymology are enabling more efficient library preparation with lower input requirements, thereby expanding the range of sample types that can be interrogated. Concurrently, improvements in automation and microfluidic handling are reducing manual variability and increasing throughput, which is particularly consequential as sequencing scales to population-level studies and routine clinical diagnostics.

These technological shifts are accompanied by a growing emphasis on standardization and interoperability. Inter-laboratory reproducibility is now a central metric for both clinical validation and collaborative research, prompting suppliers and laboratories to invest in validated kits, closed workflows, and integrated QC solutions. The convergence of wet-lab improvements and informatics-enabled QC checkpoints strengthens the traceability of samples from collection to data deliverables. Moreover, emerging approaches such as targeted enrichment refinement and low-input library methods are enabling new applications, including circulating tumor DNA profiling and single-cell analyses, which demand specialized sample preparation strategies.

As a result, organizations are rethinking procurement and operational models. There is a clear shift toward bundled solutions that integrate instruments, reagents, and services in order to minimize compatibility issues and accelerate time-to-result. This shift has strategic implications for suppliers and end users alike: suppliers must demonstrate workflow compatibility and regulatory readiness, while laboratories must balance flexibility for bespoke protocols against the efficiencies of standardized, validated kits and platforms. Ultimately, these transformative shifts are redefining expectations for performance, reliability, and lifecycle support across the sample preparation ecosystem.

Examining the operational and supply chain consequences of tariff changes and trade policy shifts on reagent sourcing, procurement strategies, and production continuity

Tariff changes and trade policy adjustments can exert immediate pressure on the supply chains that underpin reagents, instruments, and consumables necessary for next-generation sequencing sample preparation. In the United States, tariff measures announced or implemented in 2025 have introduced new cost considerations and logistical complexity for organizations that source specialized enzymes, plastics, and instrumentation components from international suppliers. These developments have prompted procurement teams to reassess vendor contracts, lead time buffers, and contingency inventories to mitigate disruption risk and maintain continuity of service.

In response to tariff-driven uncertainty, many stakeholders are diversifying supplier networks and exploring regional sourcing arrangements to reduce exposure to cross-border duties. Some laboratories have accelerated qualification of alternative reagent formats and vendor-agnostic consumables to preserve operational agility. At the same time, manufacturers are responding by adapting pricing strategies, localizing certain aspects of production, and expanding distributor partnerships to offset the immediate impacts of trade-related costs. These adjustments often come with transitional friction, including qualification cycles and potential variances in lot-to-lot performance that must be managed through rigorous QC protocols.

From an operational perspective, institutions are prioritizing supply chain resilience alongside scientific performance. This entails developing risk assessments that account for tariff volatility, lead time variability, and single-source dependencies. Simultaneously, procurement and laboratory leadership are increasingly collaborating to balance short-term continuity measures with long-term strategic sourcing, ensuring that sample preparation workflows remain robust in the face of ongoing policy and trade fluctuations. These collective responses underscore the importance of flexible procurement strategies and vendor engagement practices to preserve experimental integrity and service delivery.

Delivering nuanced segmentation intelligence that links product types, workflows, technologies, sample classes, applications, and end user priorities to guide procurement and development

Understanding the sample preparation landscape requires a granular view across multiple segmentation axes that influence purchasing behavior, workflow design, and technical compatibility. Based on product considerations, laboratories evaluate instruments, reagents and consumables, and services as distinct yet interdependent categories that together determine total workflow performance and vendor value propositions. Instruments set the technical baseline for throughput and automation; reagents and consumables govern chemistry performance and lot consistency; and services, including installation and method validation, enable accelerated adoption and operational reliability.

When viewed through the workflow lens, stakeholders place emphasis on library preparation and amplification, library quantification and quality control, nucleic acid extraction, and target enrichment as sequential phases where optimization can yield disproportionate benefits in data quality. Library preparation and amplification techniques are central to preserving representation and reducing bias, whereas robust quantification and QC prevent costly sequencing failures. Nucleic acid extraction remains the foundational step, with extraction efficiency and inhibitor removal critically shaping downstream success. Target enrichment approaches, meanwhile, dictate the specificity and sensitivity of downstream analyses for targeted panels and variant detection.

NGS technology segmentation further refines decision criteria; approaches such as ChIP sequencing, exome sequencing, methylation sequencing, RNA sequencing, targeted sequencing, and whole genome sequencing each impose different requirements for input quality, fragment size, and enrichment strategies. Sample type segmentation between DNA and RNA highlights divergent handling needs and stabilization protocols, with RNA workflows typically demanding more stringent preservation and QC. Application-driven priorities-ranging from agricultural genomics and animal science to clinical diagnostics, clinical research and drug development, consumer genomics, and forensics-shape validation requirements, throughput tolerances, and regulatory scrutiny. Finally, end users including academic and research institutions, hospitals and clinics, and pharmaceutical and biotechnology companies demonstrate unique purchasing rationales and service expectations, driving suppliers to offer differentiated commercial models and technical support to meet these varied needs.

Explaining how regional regulatory frameworks, infrastructure investments, and local sourcing trends shape procurement priorities and workflow adoption across global territories

Regional dynamics play a pivotal role in shaping procurement strategies, regulatory alignment, and the evolution of sample preparation practices. In the Americas, investment in clinical sequencing infrastructures and translational research hubs is fostering demand for automated workflows and validated kits that support high-throughput and clinical-grade operations. Laboratories in this region often emphasize rapid integration with existing instrumentation and robust after-sales support, reflecting the heavy focus on clinical adoption and large-scale research initiatives.

Across Europe, the Middle East & Africa, regulatory heterogeneity and varied healthcare infrastructures create a landscape where compliance pathways and localized validation are critical. Laboratories in this combined region increasingly seek solutions that facilitate cross-border collaboration while meeting stringent regional compliance frameworks. There is a pronounced interest in flexible workflows that can be adapted to both resource-rich urban centers and decentralized facilities that require reliable, low-complexity protocols.

In the Asia-Pacific region, rapid expansion of sequencing capacity and investments in genomics-driven healthcare and agriculture are driving demand for cost-effective, high-throughput sample preparation solutions. Local manufacturing and supply chain initiatives in several countries are beginning to influence procurement choices, encouraging suppliers to consider regional production and distribution strategies. Across all regions, however, the interplay between regulatory expectations, reimbursement environments, and research priorities shapes how organizations prioritize investments in instrumentation, reagents, and services for sample preparation.

Profiling how integrated solutions, partnership strategies, and validated performance data create competitive differentiation among suppliers in the sample preparation ecosystem

Competitive dynamics in the sample preparation space are characterized by a mix of established instrument manufacturers, specialized reagent suppliers, and service providers that deliver end-to-end workflow solutions and technical support. Many leading players focus on integrated offerings that bundle instruments with validated reagent kits and software-enabled quality control, thus reducing integration risk for end users and accelerating adoption in clinical and high-throughput research settings. Others specialize in niche chemistries or novel extraction technologies that address specific pain points, such as low-input samples or highly degraded nucleic acids.

Partnerships and channel strategies are becoming central to company differentiation. Suppliers that cultivate strong distributor networks, localized technical support, and co-development relationships with end users can more rapidly respond to demand variability and regulatory needs. Additionally, investments in method validation and published performance data increasingly serve as decision-making criteria for laboratory directors and procurement teams. Companies that demonstrate reproducible results across multiple independent studies enhance confidence among potential buyers and reduce the perceived risk associated with switching reagents or platforms.

Innovation pipelines are also influenced by cross-sector collaboration. Collaborations between reagent companies, instrument OEMs, and contract research organizations are enabling modular solutions that combine best-in-class components with managed services. This collaborative approach often yields accelerated product refinement and a broader evidence base for clinical and research applications. Consequently, competitive advantage accrues to organizations that can deliver demonstrable improvements in workflow efficiency, reproducibility, and lifecycle support, while maintaining flexibility for customization where necessary.

Presenting evidence-based, practical initiatives for vendors and laboratories to enhance validation, resilience, and customer-centric service delivery across sample preparation workflows

Industry leaders can adopt a set of pragmatic, actionable measures to strengthen their position across technical, commercial, and operational dimensions. First, invest in workflow validation and interoperability testing to ensure that instruments, kits, and consumables function predictably across diverse laboratory environments. This reduces implementation risk for customers and shortens qualification cycles. Second, prioritize transparency in performance data by publishing independent validation studies and providing clear QC metrics, enabling procurement teams to make evidence-based comparisons and accelerating trust in new solutions.

Third, enhance supply chain resilience by diversifying supplier bases, qualifying alternative reagent formats, and developing regional distribution capabilities to mitigate exposure to trade disruptions. Fourth, expand service offerings that combine technical training, method transfer, and post-sale support to maximize uptime and reduce user error. Fifth, engage proactively with regulatory stakeholders and clinical partners to anticipate compliance requirements and align product development with clinical evidence needs. By doing so, organizations can position themselves as trusted collaborators for translational research and diagnostic adoption.

Finally, adopt a customer-centric commercial model that balances standardized, validated kits for rapid deployment with configurable solutions for specialized applications. This hybrid approach supports scalability while preserving the flexibility required by advanced research programs. Implementing these recommendations enhances operational robustness, strengthens customer relationships, and accelerates the translation of technical innovations into reliable laboratory practice.

Outlining the rigorous, transparent research approach that integrates primary interviews, technical literature, and supplier documentation to ensure actionable and reproducible findings

This research synthesizes qualitative and quantitative inputs from primary interviews, technical literature, and product documentation to develop a comprehensive understanding of sample preparation practices and supplier strategies. Primary engagement included structured discussions with laboratory directors, procurement leads, R&D heads at reagent and instrument manufacturers, and technical service managers across academic, clinical, and commercial settings. These conversations explored workflow pain points, validation practices, vendor selection criteria, and supply chain considerations, providing first-hand context for observed industry dynamics.

Secondary sources comprised peer-reviewed publications, regulatory guidance documents, and manufacturer technical notes that describe methods, performance characteristics, and validation approaches. Analytical emphasis was placed on method comparability, reproducibility metrics, and the operational implications of reagent and instrument choices. Additionally, the research team evaluated product integration and support offerings through supplier documentation and publicly available technical information to triangulate claims with laboratory experiences.

The analytical framework combined thematic synthesis with comparative evaluation across segmentation axes to identify common drivers of adoption, technical trade-offs, and supplier differentiation. Throughout the process, attention was paid to ensuring methodological transparency and reproducibility of findings, with a focus on delivering insights that inform strategic decisions without relying on proprietary commercial estimations.

Summarizing the strategic imperative to prioritize validated, interoperable, and resilient sample preparation practices to sustain sequencing reliability and translational impact

In conclusion, optimizing sample preparation is an indispensable strategic priority for any organization seeking reliable, high-quality sequencing data. Technical refinements in reagents, automation, and QC have a direct bearing on the reproducibility and sensitivity of downstream analyses, while supply chain and regulatory dynamics shape procurement choices and operational resilience. Stakeholders must therefore evaluate sample preparation as a strategic investment that influences experiment success rates, laboratory throughput, and the credibility of scientific findings.

The converging trends toward integrated solutions, regional sourcing adjustments, and evidence-based validation signal a maturing ecosystem that rewards transparency, interoperability, and service excellence. Organizations that proactively address compatibility, validation, and supply continuity will be better positioned to capitalize on scientific opportunities and to mitigate operational disruptions. Ultimately, judicious investments in sample preparation practices and supplier partnerships translate into more reliable sequencing outputs, accelerated translational impact, and enhanced confidence among clinical and research users.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of microfluidic-based platforms enabling single-cell library preparation with minimal input requirements
  • 5.2. Development of low-input and ultra-low-input library kits optimized for cfDNA and liquid biopsy samples
  • 5.3. Integration of automation and robotics in high-throughput NGS sample preparation workflows for scalability
  • 5.4. Adoption of enzymatic DNA fragmentation techniques replacing mechanical shearing to improve library integrity
  • 5.5. Innovative barcoding and unique molecular identifier approaches to reduce amplification bias in multiplex assays
  • 5.6. Advances in targeted enrichment probes enabling highly specific capture of rare genomic variants from complex samples
  • 5.7. Implementation of real-time quality control and normalization systems to minimize library preparation failures
  • 5.8. Growing adoption of end-to-end sample-to-sequencer platforms to accelerate clinical NGS diagnostic pipelines

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Next-Generation Sequencing Sample Preparation Market, by Product

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
  • 8.3. Services

9. Next-Generation Sequencing Sample Preparation Market, by Workflow

  • 9.1. Library Preparation & Amplification
  • 9.2. Library Quantification/QC
  • 9.3. Nucleic Acid Extraction
  • 9.4. Target Enrichment

10. Next-Generation Sequencing Sample Preparation Market, by NGS Technology

  • 10.1. ChIP Sequencing (Chromatin Immunoprecipitation)
  • 10.2. Exome Sequencing
  • 10.3. Methylation Sequencing
  • 10.4. RNA Sequencing (RNA-Seq)
  • 10.5. Targeted Sequencing
  • 10.6. Whole Genome Sequencing (WGS)

11. Next-Generation Sequencing Sample Preparation Market, by Sample Type

  • 11.1. DNA
  • 11.2. RNA

12. Next-Generation Sequencing Sample Preparation Market, by Application

  • 12.1. Agricultural Genomics
  • 12.2. Animal Science & Veterinary Research
  • 12.3. Clinical Diagnostics
  • 12.4. Clinical Research & Drug Development
  • 12.5. Consumer Genomics
  • 12.6. Forensics

13. Next-Generation Sequencing Sample Preparation Market, by End User

  • 13.1. Academic & Research Institutions
  • 13.2. Hospitals & Clinics
  • 13.3. Pharmaceutical & Biotechnology Companies

14. Next-Generation Sequencing Sample Preparation Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Next-Generation Sequencing Sample Preparation Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Next-Generation Sequencing Sample Preparation Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Agilent Technologies, Inc.
    • 17.3.2. Azenta Life Sciences
    • 17.3.3. BGI Genomics Co., Ltd.
    • 17.3.4. Biodiscovery, LLC
    • 17.3.5. Bio-Rad Laboratories, Inc.
    • 17.3.6. Charles River Laboratories International, Inc
    • 17.3.7. Danaher Corporation
    • 17.3.8. F. Hoffmann-La Roche Ltd
    • 17.3.9. GenScript Biotech Corporation
    • 17.3.10. Hamilton Bonaduz AG
    • 17.3.11. Illumina, Inc.
    • 17.3.12. LGC Biosearch Technologies
    • 17.3.13. Merck KGaA
    • 17.3.14. Meridian Bioscience, Inc
    • 17.3.15. New England Biolabs, Inc
    • 17.3.16. NimaGen B.V.
    • 17.3.17. Omega Bio-tek, Inc.
    • 17.3.18. Oxford Nanopore Technologies PLC
    • 17.3.19. Pacific Biosciences of California, Inc.
    • 17.3.20. Parse Biosciences
    • 17.3.21. PerkinElmer, Inc.
    • 17.3.22. Promega Corporation
    • 17.3.23. QIAGEN N.V.
    • 17.3.24. Standard BioTools Inc.
    • 17.3.25. Takara Bio Inc.
    • 17.3.26. Thermo Fisher Scientific, Inc.
    • 17.3.27. Twist Bioscience Corporation
    • 17.3.28. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2024 (U